SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-085814
Filing Date
2020-07-23
Accepted
2020-07-23 07:05:32
Documents
7
Period of Report
2020-07-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2025424-1_8k.htm 8-K 25664
2 EXHIBIT 4.1 tm2025424d1_ex4-1.htm EX-4.1 65391
3 EXHIBIT 10.1 tm2025424d1_ex10-1.htm EX-10.1 165911
4 EXHIBIT 99.1 tm2025424d1_ex99-1.htm EX-99.1 22748
5 EXHIBIT 99.2 tm2025424d1_ex99-2.htm EX-99.2 11609
6 GRAPHIC tm2025424d1_ex99-1img001.jpg GRAPHIC 4556
7 GRAPHIC tm2025424d1_ex99-2img001.jpg GRAPHIC 14673
  Complete submission text file 0001104659-20-085814.txt   319408
Mailing Address 1111 DR. FREDERIK-PHILIPS BLVD SUITE 420 MONTREAL A8 H4M 2X6
Business Address 1111 DR. FREDERIK-PHILIPS BLVD SUITE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Filer) CIK: 0001408443 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38899 | Film No.: 201042724
SIC: 2834 Pharmaceutical Preparations